Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)
China
· Delayed Price · Currency is CNY
61.90
-0.86 (-1.37%)
Jan 27, 2025, 3:04 PM CST
Shenzhen New Industries Biomedical Engineering Revenue
Shenzhen New Industries Biomedical Engineering had revenue of 1.20B CNY in the quarter ending September 30, 2024, with 15.38% growth. This brings the company's revenue in the last twelve months to 4.44B, up 21.25% year-over-year. In the year 2023, Shenzhen New Industries Biomedical Engineering had annual revenue of 3.93B with 28.97% growth.
Revenue (ttm)
4.44B
Revenue Growth
+21.25%
P/S Ratio
10.96
Revenue / Employee
1.69M
Employees
2,627
Market Cap
48.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.93B | 882.70M | 28.97% |
Jan 1, 2023 | 3.05B | 501.54M | 19.70% |
Jan 1, 2022 | 2.55B | 350.45M | 15.97% |
Dec 31, 2020 | 2.19B | 513.38M | 30.53% |
Dec 31, 2019 | 1.68B | 297.98M | 21.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.93B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |